Cohen Neil Harris — SEC insider filings
SEC reporting owner CIK 1840006. 10 insider filings on record with FilingPulse; latest filed 2026-09-01.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2021-03-11 to 2026-09-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 6 legs across 4 filings — 12,409 shares, $147,358 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 3 legs across 2 filings — 4,713 shares, $11,334 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 24.
- Largest priced transaction: purchase of 2,409 shares @ $41.51 ($99,998) in Chemomab Therapeutics Ltd., filed 2021-03-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Chemomab Therapeutics Ltd. (CMMB) | Director | 10 | 6 legs · 12,409 sh · $147,358 | 3 legs · 4,713 sh · $11,334 | 24 |
Insider filings — Cohen Neil Harris
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-01 | 4 | Chemomab Therapeutics Ltd. (CMMB) | Sale (S): 1,304 @ $2.85 · Sale (S): 1,000 @ $2.80 · Grant/award (A): 172 (derivative) @ $0 · Grant/award (A): 2,971 (derivative) @ $0 · Grant/award (A): 1,705 (derivative) @ $0 · Grant/award (A): 1,714 (derivative) @ $0 · +3 more | EDGAR |
| 2023-03-23 | 4 | Chemomab Therapeutics Ltd. (CMMB) | Grant/award (A): 6,875 (derivative) @ $0 · Grant/award (A): 6,820 (derivative) @ $0 · Grant/award (A): 11,884 (derivative) @ $0 · Grant/award (A): 688 (derivative) @ $0 | EDGAR |
| 2022-11-18 | 4 | Chemomab Therapeutics Ltd. (CMMB) | Sale (S): 2,409 @ $2 · Grant/award (A): 6,820 (derivative) @ $0 · Grant/award (A): 11,884 (derivative) @ $0 · Grant/award (A): 688 (derivative) @ $0 | EDGAR |
| 2022-05-19 | 4 | Chemomab Therapeutics Ltd. (CMMB) | Purchase (P): 2,000 @ $3.19 · Grant/award (A): 6,820 (derivative) @ $0 · Grant/award (A): 11,884 (derivative) @ $0 · Grant/award (A): 688 (derivative) @ $0 | EDGAR |
| 2022-03-15 | 4 | Chemomab Therapeutics Ltd. (CMMB) | Purchase (P): 2,000 @ $4.20 · Purchase (P): 2,000 @ $4.30 · Purchase (P): 2,000 @ $4.56 · Grant/award (A): 6,820 (derivative) @ $0 · Grant/award (A): 11,884 (derivative) @ $0 · Grant/award (A): 688 (derivative) @ $0 | EDGAR |
| 2022-03-09 | 4 | Chemomab Therapeutics Ltd. (CMMB) | Grant/award (A): 6,820 (derivative) @ $0 | EDGAR |
| 2021-12-08 | 4 | Chemomab Therapeutics Ltd. (CMMB) | Purchase (P): 2,000 @ $7.43 | EDGAR |
| 2021-04-21 | 4 | Chemomab Therapeutics Ltd. (CMMB) | Grant/award (A): 11,884 (derivative) @ $0 | EDGAR |
| 2021-03-26 | 4 | Chemomab Therapeutics Ltd. (CMMB) | Purchase (P): 2,409 @ $41.51 · Purchase (P): 688 (derivative) @ $0 | EDGAR |
| 2021-03-11 | 4 | Anchiano Therapeutics Ltd. (ANCN) | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-03-08 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1840006 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs